NewAmsterdam Pharma Co N.V.

Nasdaq:NAMSNasdaq:NAMSW

Pharmaceutical Preparations·NARRDEN, P7

Financials

9 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/18/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	2/26/25	→
10-Q	Q3 2024	9/30/24	11/6/24	→
↓

Earnings Releases (8-K)

10 shown

Filed	Period
2/18/26	Q1 FY2026	→
1/9/26	Q4 FY2026	→
11/5/25	Q4 FY2025	→
8/6/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
2/26/25	Q1 FY2025	→
↓

News (8-K)

29 shown

Filed	Type	Description
3/2/26	Reg FD	Regulation FD Disclosure	→
9/2/25	Reg FD	Regulation FD Disclosure	→
8/18/25	Reg FD	Regulation FD Disclosure	→
8/15/25	Agreement	Entry into a Material Definitive Agreement	→
7/30/25	Reg FD	Regulation FD Disclosure	→
7/11/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

37 shown

Filed	Form	Description
2/18/26	S-8	S-8	→
5/8/25	ARS	ARS	→
3/10/25	424B3	424B3	→
2/28/25	S-3	S-3	→
1/7/25	S-8	S-8	→
12/13/24	424B5	424B5	→
↓

Filing History(375 filings)

TypeDateAccessionPeriodSize

144

Mar 6, 2026

0001968582-26-000241

—

7.5 KB

144

Mar 5, 2026

0001968582-26-000230

—

4.5 KB

Mar 2, 2026

0001193125-26-0859474

Mar 2, 2026

8.4 KB

144

Mar 2, 2026

0001968582-26-000187

—

6.9 KB

8-K

Mar 2, 2026

0001193125-26-0842668-K

Mar 2, 2026

17.7 MB

Feb 26, 2026

0001193125-26-0787184

Feb 24, 2026

27.5 KB

Feb 24, 2026

0001193125-26-0672604

Feb 20, 2026

6.7 KB

144

Feb 24, 2026

0001968582-26-000152

—

4.5 KB

144

Feb 20, 2026

0002085929-26-000002

—

5.0 KB

S-8

Feb 18, 2026

0001193125-26-056037S-8

—

542.5 KB

10-K

Feb 18, 2026

0001193125-26-05602910-K

Dec 31, 2025

17.5 MB

8-K

Feb 18, 2026

0001193125-26-0560208-K

Feb 18, 2026

841.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0000905148-26-000880

—

38.8 KB

SCHEDULE 13G

Feb 5, 2026

0000315066-26-000486

—

11.1 KB

Jan 29, 2026

0001193125-26-0295264

Jan 27, 2026

13.6 KB

Jan 27, 2026

0001193125-26-0250124

Jan 23, 2026

17.2 KB

Jan 22, 2026

0001193125-26-0196864

Jan 20, 2026

19.2 KB

144

Jan 20, 2026

0001968582-26-000040

—

4.5 KB

Jan 9, 2026

0001193125-26-0092744

Jan 7, 2026

7.1 KB

Jan 9, 2026

0001193125-26-0092734

Jan 7, 2026

7.0 KB

Jan 9, 2026

0001193125-26-0092724

Jan 7, 2026

9.3 KB

Jan 9, 2026

0001193125-26-0092714

Jan 7, 2026

7.0 KB

Jan 9, 2026

0001193125-26-0092704

Jan 7, 2026

7.0 KB

Jan 9, 2026

0001193125-26-0092694

Jan 7, 2026

7.0 KB

Jan 9, 2026

0001193125-26-0092684

Jan 7, 2026

7.6 KB

25 filings shown

Filed	Form	Description
5/8/25	DEF 14A	DEF 14A	→
4/28/25	PRE 14A	PRE 14A	→
5/9/24	DEF 14A	DEF 14A	→
4/29/24	PRE 14A	PRE 14A	→

NewAmsterdam Pharma Co N.V.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(375 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/2/26	4	4	→
2/26/26	4	4	→
2/24/26	4	4	→
1/29/26	4	4	→
1/27/26	4	4	→
1/22/26	4	4	→
↓

Filed	Form	Description
3/6/26	144	144	→
3/5/26	144	144	→
3/2/26	144	144	→
2/24/26	144	144	→
2/20/26	144	144	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓